Pearl River Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,729
| Closed | -$554K | – | 52 |
|
|
2024
Q2 | $554K | Buy |
6,729
+2,851
| +74% | +$235K | 0.09% | 265 |
|
|
2024
Q1 | $339K | Buy |
+3,878
| New | +$339K | 0.05% | 371 |
|
|
2023
Q3 | – | Sell |
-9,579
| Closed | -$830K | – | 497 |
|
|
2023
Q2 | $830K | Buy |
+9,579
| New | +$830K | 0.13% | 232 |
|
|
2023
Q1 | – | Sell |
-6,297
| Closed | -$652K | – | 502 |
|
|
2022
Q4 | $652K | Sell |
6,297
-19,026
| -75% | -$1.97M | 0.11% | 279 |
|
|
2022
Q3 | $2.15M | Buy |
25,323
+12,228
| +93% | +$1.04M | 0.4% | 69 |
|
|
2022
Q2 | $1.09M | Sell |
13,095
-6,866
| -34% | -$569K | 0.26% | 128 |
|
|
2022
Q1 | $1.54M | Buy |
+19,961
| New | +$1.54M | 0.42% | 68 |
|
|
2020
Q2 | – | Sell |
-1,527
| Closed | -$129K | – | 310 |
|
|
2020
Q1 | $129K | Buy |
+1,527
| New | +$129K | 0.25% | 138 |
|
|
2019
Q1 | – | Sell |
-100
| Closed | -$9K | – | 396 |
|
|
2018
Q4 | $9K | Buy |
+100
| New | +$9K | 0.04% | 590 |
|